Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
The present disclosure relates to compounds that are useful as near-infrared fluorescence probes, wherein the compounds include i) a pteroyl ligand that binds to a target receptor protein, ii) a dye molecule, and iii) a linker molecule that comprises an amino acid or derivative thereof. The disclosure further describes methods and compositions for making and using the compounds, methods incorporating the compounds, and kits incorporating the compounds.
1. A kit comprising a compound having the formula:
or a pharmaceutically acceptable salt thereof,
or isotopes thereof, wherein:
X is an single amino acid or a single amino acid derivative thereof, wherein the single amino acid or single amino acid derivative contains an —OH, —NH2, or —SH functional group, and
Y is a dye that has a fluorescence excitation and emission spectra in the near infra red range, wherein Y is represented by the formula:
wherein, X′ is independently selected from the group consisting of O, S, N and C, and
R′ is independently selected from the group consisting of CH 2 and CH 2 CH 2 ,
and the compound maintains or enhances the fluorescence of the dye, Y.
2. The kit of claim 1 wherein the amino acid is selected from the group consisting of tyrosine, cysteine, lysine, serine or a derivative thereof of tyrosine or cysteine.
3. The kit of claim 1 wherein the amino acid is tyrosine, wherein the aromatic ring of tyrosine comprises a carbon isotope and/or a hydrogen isotope.
4. The kit of claim 1 wherein the amino acid derivative is a derivative of tyrosine selected from the group consisting of:
or racemic mixtures thereof.
5. The kit of claim 1 wherein the amino acid including a sulfur-containing side chain group is cysteine.
6. The kit of claim 1 wherein the compound has the formula:
or is a potassium, sodium, or ammonium salt thereof.
7. The kit of claim 1 wherein the compound has the formula:
or a pharmaceutically acceptable salt thereof.
8. The kit of claim 1 wherein the compound has an absorption and emission maxima between about 600 nm and 800 nm.
9. The kit of claim 1 wherein the compound is made to fluoresce after distribution thereof in the tissue cells.
10. The kit of claim 1 wherein the compound is highly selective for targeting to a tumor cell.
11. The kit of claim 1 , wherein the kit further comprises a pharmaceutically acceptable carrier, excipient or diluent.